Caseware UK (AP4) 2023.0.135 2023.0.135 2024-08-312024-08-312trueNo description of principal activityfalse2023-08-10truefalseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 15062938 2023-08-09 15062938 2023-08-10 2024-08-31 15062938 2022-08-10 2023-08-09 15062938 2024-08-31 15062938 c:Director1 2023-08-10 2024-08-31 15062938 d:CurrentFinancialInstruments 2024-08-31 15062938 d:CurrentFinancialInstruments d:WithinOneYear 2024-08-31 15062938 d:ShareCapital 2024-08-31 15062938 d:RetainedEarningsAccumulatedLosses 2024-08-31 15062938 c:FRS102 2023-08-10 2024-08-31 15062938 c:AuditExempt-NoAccountantsReport 2023-08-10 2024-08-31 15062938 c:FullAccounts 2023-08-10 2024-08-31 15062938 c:PrivateLimitedCompanyLtd 2023-08-10 2024-08-31 15062938 6 2023-08-10 2024-08-31 15062938 e:PoundSterling 2023-08-10 2024-08-31 iso4217:GBP xbrli:pure

Registered number: 15062938










DR NEWCO LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE PERIOD ENDED 31 AUGUST 2024

 
DR NEWCO LIMITED
REGISTERED NUMBER: 15062938

BALANCE SHEET
AS AT 31 AUGUST 2024

2024
Note
£

Fixed assets
  

Investments
 4 
2,430,520

  
2,430,520

Current assets
  

Cash at bank and in hand
 5 
100

  
100

Creditors: amounts falling due within one year
 6 
(2,431,020)

Net current (liabilities)/assets
  
 
 
(2,430,920)

Total assets less current liabilities
  
(400)

  

Net (liabilities)/assets
  
(400)


Capital and reserves
  

Called up share capital 
  
100

Profit and loss account
  
(500)

  
(400)


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 24 December 2024.




R J Cox
Director
Page 1

 
DR NEWCO LIMITED
REGISTERED NUMBER: 15062938
    
BALANCE SHEET (CONTINUED)
AS AT 31 AUGUST 2024


The notes on pages 3 to 4 form part of these financial statements.

Page 2

 
DR NEWCO LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 AUGUST 2024

1.


General information

DR Newco Limited is a private company, limited by shares and incorporated in England and Wales.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the Profit and loss account for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

Investments in listed company shares are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.

 
2.3

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.4

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the period was 2.

Page 3

 
DR NEWCO LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 AUGUST 2024

4.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


Additions
2,430,520



At 31 August 2024
2,430,520





5.


Cash and cash equivalents

2024
£

Cash at bank and in hand
100

100



6.


Creditors: Amounts falling due within one year

2024
£

Amounts owed to group undertakings
2,351,648

Other creditors
78,872

Accruals and deferred income
500

2,431,020


 
Page 4